http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018148791-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3127c0ebee3f865b211b019fac84286
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-1032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-1031
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B25-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10
filingDate 2016-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61b945064befd27e42e1e7e1aa067aa1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa7b7bcf87144648b8c42afc7f0d3c47
publicationDate 2018-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2018148791-A1
titleOfInvention Systems and methods for providing personalized radiation therapy
abstract An example method of treating a subject having a tumor is described herein. The method can include determining a radiosensitivity index of the tumor, deriving a subject-specific variable based on the radiosensitivity index, and obtaining a genomic adjusted radiation dose effect value for the tumor. The radiosensitivity index can be assigned from expression levels of signature genes of a cell of the tumor. Additionally, the genomic adjusted radiation dose effect value can be predictive of tumor recurrence in the subject after treatment. The method can also include determining a radiation dose based on the subject-specific variable and the genomic adjusted radiation dose effect value.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020082071-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021051052-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10556125-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11439843-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018296856-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11547871-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11426603-B2
priorityDate 2015-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016008629-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016146819-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016054337-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012004492-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014363816-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID247704
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226419983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2576

Total number of triples: 46.